Rank | Gene Set | Z-score |
---|---|---|
1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.86077340 |
2 | L-phenylalanine catabolic process (GO:0006559) | 6.86077340 |
3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.54416618 |
4 | L-phenylalanine metabolic process (GO:0006558) | 6.54416618 |
5 | aromatic amino acid family catabolic process (GO:0009074) | 6.30288433 |
6 | angiotensin maturation (GO:0002003) | 6.02326582 |
7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.98582398 |
8 | tryptophan catabolic process (GO:0006569) | 5.90652517 |
9 | indole-containing compound catabolic process (GO:0042436) | 5.90652517 |
10 | indolalkylamine catabolic process (GO:0046218) | 5.90652517 |
11 | kynurenine metabolic process (GO:0070189) | 5.70925343 |
12 | tryptophan metabolic process (GO:0006568) | 5.64121573 |
13 | bile acid biosynthetic process (GO:0006699) | 5.37297959 |
14 | alpha-linolenic acid metabolic process (GO:0036109) | 5.17503348 |
15 | urea cycle (GO:0000050) | 5.13453818 |
16 | urea metabolic process (GO:0019627) | 5.13453818 |
17 | glyoxylate metabolic process (GO:0046487) | 5.07168279 |
18 | high-density lipoprotein particle remodeling (GO:0034375) | 5.02897972 |
19 | sulfur amino acid catabolic process (GO:0000098) | 5.02615991 |
20 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.98636086 |
21 | protein carboxylation (GO:0018214) | 4.94246812 |
22 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.94246812 |
23 | complement activation, alternative pathway (GO:0006957) | 4.92868910 |
24 | cysteine metabolic process (GO:0006534) | 4.86997278 |
25 | regulation of protein activation cascade (GO:2000257) | 4.82274444 |
26 | regulation of cholesterol esterification (GO:0010872) | 4.80769352 |
27 | negative regulation of fibrinolysis (GO:0051918) | 4.78672973 |
28 | nitrogen cycle metabolic process (GO:0071941) | 4.70994780 |
29 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.69015752 |
30 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 4.66342649 |
31 | bile acid metabolic process (GO:0008206) | 4.64997770 |
32 | regulation of fibrinolysis (GO:0051917) | 4.63405650 |
33 | regulation of complement activation (GO:0030449) | 4.54673364 |
34 | regulation of triglyceride catabolic process (GO:0010896) | 4.54384401 |
35 | aromatic amino acid family metabolic process (GO:0009072) | 4.52676562 |
36 | lysine metabolic process (GO:0006553) | 4.51248875 |
37 | lysine catabolic process (GO:0006554) | 4.51248875 |
38 | reverse cholesterol transport (GO:0043691) | 4.51213191 |
39 | protein-lipid complex remodeling (GO:0034368) | 4.46091314 |
40 | macromolecular complex remodeling (GO:0034367) | 4.46091314 |
41 | plasma lipoprotein particle remodeling (GO:0034369) | 4.46091314 |
42 | phospholipid efflux (GO:0033700) | 4.44380964 |
43 | epoxygenase P450 pathway (GO:0019373) | 4.39815825 |
44 | homocysteine metabolic process (GO:0050667) | 4.38731641 |
45 | amine catabolic process (GO:0009310) | 4.36024128 |
46 | cellular biogenic amine catabolic process (GO:0042402) | 4.36024128 |
47 | serine family amino acid catabolic process (GO:0009071) | 4.31170638 |
48 | negative regulation of sterol transport (GO:0032372) | 4.28379504 |
49 | negative regulation of cholesterol transport (GO:0032375) | 4.28379504 |
50 | tyrosine metabolic process (GO:0006570) | 4.27684487 |
51 | hormone catabolic process (GO:0042447) | 4.22722548 |
52 | amino-acid betaine metabolic process (GO:0006577) | 4.20656202 |
53 | lipoprotein transport (GO:0042953) | 4.18098523 |
54 | indolalkylamine metabolic process (GO:0006586) | 4.15835150 |
55 | bile acid and bile salt transport (GO:0015721) | 4.15797229 |
56 | drug catabolic process (GO:0042737) | 4.15471700 |
57 | alpha-amino acid catabolic process (GO:1901606) | 4.15037829 |
58 | NADH metabolic process (GO:0006734) | 4.11732181 |
59 | low-density lipoprotein particle remodeling (GO:0034374) | 4.07332607 |
60 | cholesterol efflux (GO:0033344) | 4.07307971 |
61 | ethanol oxidation (GO:0006069) | 4.07288385 |
62 | acylglycerol homeostasis (GO:0055090) | 4.06891122 |
63 | triglyceride homeostasis (GO:0070328) | 4.06891122 |
64 | plasma lipoprotein particle assembly (GO:0034377) | 4.04707862 |
65 | cellular glucuronidation (GO:0052695) | 4.04309859 |
66 | plasma lipoprotein particle clearance (GO:0034381) | 4.02812746 |
67 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.98061070 |
68 | coenzyme catabolic process (GO:0009109) | 3.86697571 |
69 | glutamate metabolic process (GO:0006536) | 3.86027597 |
70 | benzene-containing compound metabolic process (GO:0042537) | 3.85387777 |
71 | exogenous drug catabolic process (GO:0042738) | 3.84495619 |
72 | cellular amino acid catabolic process (GO:0009063) | 3.83549747 |
73 | cellular modified amino acid catabolic process (GO:0042219) | 3.82646955 |
74 | intestinal absorption (GO:0050892) | 3.82520231 |
75 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.80634662 |
76 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.80562887 |
77 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.76349348 |
78 | omega-hydroxylase P450 pathway (GO:0097267) | 3.72825105 |
79 | complement activation, classical pathway (GO:0006958) | 3.71243718 |
80 | flavonoid metabolic process (GO:0009812) | 3.70787288 |
81 | protein-lipid complex assembly (GO:0065005) | 3.68230115 |
82 | phospholipid homeostasis (GO:0055091) | 3.65000503 |
83 | imidazole-containing compound metabolic process (GO:0052803) | 3.64288408 |
84 | plasma lipoprotein particle organization (GO:0071827) | 3.61933973 |
85 | complement activation (GO:0006956) | 3.61706672 |
86 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.60896909 |
87 | glucuronate metabolic process (GO:0019585) | 3.59847931 |
88 | uronic acid metabolic process (GO:0006063) | 3.59847931 |
89 | glycine metabolic process (GO:0006544) | 3.58928623 |
90 | cellular ketone body metabolic process (GO:0046950) | 3.55843267 |
91 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.54796839 |
92 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.54796839 |
93 | valine metabolic process (GO:0006573) | 3.52636131 |
94 | serine family amino acid metabolic process (GO:0009069) | 3.52449318 |
95 | protein activation cascade (GO:0072376) | 3.52369605 |
96 | intestinal cholesterol absorption (GO:0030299) | 3.52332085 |
97 | short-chain fatty acid metabolic process (GO:0046459) | 3.51671053 |
98 | regulation of cholesterol homeostasis (GO:2000188) | 3.51328260 |
99 | cholesterol homeostasis (GO:0042632) | 3.50427530 |
100 | positive regulation of lipid catabolic process (GO:0050996) | 3.47624345 |
101 | regulation of bile acid biosynthetic process (GO:0070857) | 3.46971076 |
102 | arginine metabolic process (GO:0006525) | 3.46094562 |
103 | cofactor catabolic process (GO:0051187) | 3.44889678 |
104 | organic acid catabolic process (GO:0016054) | 3.44739427 |
105 | carboxylic acid catabolic process (GO:0046395) | 3.44739427 |
106 | sterol homeostasis (GO:0055092) | 3.44235628 |
107 | protein-lipid complex subunit organization (GO:0071825) | 3.43512951 |
108 | negative regulation of lipase activity (GO:0060192) | 3.43012965 |
109 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.42960371 |
110 | acetyl-CoA metabolic process (GO:0006084) | 3.42141620 |
111 | fibrinolysis (GO:0042730) | 3.42022367 |
112 | drug metabolic process (GO:0017144) | 3.40419107 |
113 | fructose metabolic process (GO:0006000) | 3.34649229 |
114 | peptide catabolic process (GO:0043171) | 3.33466577 |
115 | glycosphingolipid catabolic process (GO:0046479) | 3.21966796 |
116 | alkaloid metabolic process (GO:0009820) | 3.20638446 |
117 | regulation of cellular extravasation (GO:0002691) | 3.11207934 |
118 | detection of other organism (GO:0098543) | 3.08490559 |
119 | glycolipid catabolic process (GO:0019377) | 3.08432311 |
120 | adhesion of symbiont to host (GO:0044406) | 3.00105510 |
121 | detection of bacterium (GO:0016045) | 2.99132398 |
122 | regulation of guanylate cyclase activity (GO:0031282) | 2.98517088 |
123 | adhesion of symbiont to host cell (GO:0044650) | 2.93592707 |
124 | virion attachment to host cell (GO:0019062) | 2.93592707 |
125 | negative regulation of cell killing (GO:0031342) | 2.93294234 |
126 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.93294234 |
127 | ethanol metabolic process (GO:0006067) | 2.91669844 |
128 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.90260112 |
129 | lipoprotein metabolic process (GO:0042157) | 2.82658903 |
130 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 2.81094191 |
131 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 2.81094191 |
132 | endocrine process (GO:0050886) | 2.81094191 |
133 | phenylpropanoid metabolic process (GO:0009698) | 2.74866546 |
134 | detection of external biotic stimulus (GO:0098581) | 2.68683390 |
135 | ceramide catabolic process (GO:0046514) | 2.67265232 |
136 | drug transport (GO:0015893) | 2.63568319 |
137 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.61428519 |
138 | diacylglycerol metabolic process (GO:0046339) | 2.59750898 |
139 | leukotriene metabolic process (GO:0006691) | 2.58335280 |
140 | drug transmembrane transport (GO:0006855) | 2.54712207 |
141 | arachidonic acid metabolic process (GO:0019369) | 2.54336233 |
142 | renal system process involved in regulation of blood volume (GO:0001977) | 2.50719200 |
143 | regulation of gamma-delta T cell activation (GO:0046643) | 2.49370429 |
144 | peptide hormone processing (GO:0016486) | 2.47957204 |
145 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.46761674 |
146 | regulation of vitamin metabolic process (GO:0030656) | 2.42630180 |
147 | detection of molecule of bacterial origin (GO:0032490) | 2.41998363 |
148 | immunoglobulin mediated immune response (GO:0016064) | 2.41176220 |
149 | regulation of systemic arterial blood pressure (GO:0003073) | 2.36811277 |
150 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.34261250 |
151 | vitamin D metabolic process (GO:0042359) | 2.33891198 |
152 | heme transport (GO:0015886) | 2.33340487 |
153 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.32463122 |
154 | acute-phase response (GO:0006953) | 2.31900911 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.38788651 |
2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.52116196 |
3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.11357643 |
4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.89780865 |
5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.66474132 |
6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.37821275 |
7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.37335244 |
8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.63749800 |
9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.61580099 |
10 | GATA1_22025678_ChIP-Seq_K562_Human | 2.78026290 |
11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.70222163 |
12 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.02679299 |
13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.4431853 |
14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.95257513 |
15 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.94497503 |
16 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.91401947 |
17 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.67507947 |
18 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.63345998 |
19 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.63213634 |
20 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.61278710 |
21 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.59187004 |
22 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.53921035 |
23 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.53508348 |
24 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.52518356 |
25 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.51258976 |
26 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.44573224 |
27 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.43338622 |
28 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.42936778 |
29 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.40081480 |
30 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.35669649 |
31 | SPI1_23127762_ChIP-Seq_K562_Human | 1.33446099 |
32 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.31430463 |
33 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.30631777 |
34 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.29824196 |
35 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.29667284 |
36 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.29311131 |
37 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.28047238 |
38 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.26492957 |
39 | GATA1_19941826_ChIP-Seq_K562_Human | 1.24243812 |
40 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.21604167 |
41 | MYB_26560356_Chip-Seq_TH2_Human | 1.21287447 |
42 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.20629805 |
43 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.19653709 |
44 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.17189298 |
45 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.16761388 |
46 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.13975852 |
47 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.13406295 |
48 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.13114520 |
49 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.10881677 |
50 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.10125142 |
51 | MYB_26560356_Chip-Seq_TH1_Human | 1.06763609 |
52 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.04775658 |
53 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.03949740 |
54 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00006206 |
55 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.99258812 |
56 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.97015687 |
57 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.96311624 |
58 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.96159736 |
59 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.96059565 |
60 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.94623947 |
61 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94562825 |
62 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.93956648 |
63 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.93842759 |
64 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93670935 |
65 | GATA2_19941826_ChIP-Seq_K562_Human | 0.93596040 |
66 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91221929 |
67 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.85865446 |
68 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.85814134 |
69 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.85486146 |
70 | GATA3_26560356_Chip-Seq_TH2_Human | 0.85142167 |
71 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85055528 |
72 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.82644802 |
73 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82432210 |
74 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.82050744 |
75 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.81337233 |
76 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.80837566 |
77 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.80296775 |
78 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.80085718 |
79 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79984679 |
80 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.79887296 |
81 | UTX_26944678_Chip-Seq_JUKART_Human | 0.79779018 |
82 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.79690907 |
83 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.77089680 |
84 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.75708503 |
85 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.73314908 |
86 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.73094424 |
87 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.72547515 |
88 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.71640380 |
89 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.71312377 |
90 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.70863440 |
91 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.70838338 |
92 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.70237584 |
93 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.70110664 |
94 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.69456213 |
95 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.66845664 |
96 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.65625888 |
97 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.65174311 |
98 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.62641617 |
99 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.62407263 |
100 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.62272818 |
101 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.62084099 |
102 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.60632944 |
103 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.60540253 |
104 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.59786808 |
105 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.59523220 |
106 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.59523220 |
107 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.59493357 |
108 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.58909398 |
109 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.58553556 |
110 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.58164015 |
111 | AR_20517297_ChIP-Seq_VCAP_Human | 0.57280060 |
112 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.54497284 |
113 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.54489277 |
114 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.54419654 |
115 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.52740109 |
116 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.52594908 |
117 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.52286647 |
118 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.51835379 |
119 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.51579526 |
120 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.51326879 |
121 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.51004623 |
122 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.50843762 |
123 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.50795618 |
124 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.50436851 |
125 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.50429202 |
126 | MAF_26560356_Chip-Seq_TH1_Human | 0.50131951 |
127 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.49769526 |
128 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.48961252 |
129 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.48728610 |
130 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.48393185 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 7.48141414 |
2 | MP0005360_urolithiasis | 6.82037561 |
3 | MP0005085_abnormal_gallbladder_physiolo | 5.72350583 |
4 | MP0005365_abnormal_bile_salt | 5.41291912 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.99276685 |
6 | MP0003252_abnormal_bile_duct | 3.79470388 |
7 | MP0003806_abnormal_nucleotide_metabolis | 3.62942341 |
8 | MP0009840_abnormal_foam_cell | 3.58994011 |
9 | MP0010329_abnormal_lipoprotein_level | 3.30276410 |
10 | MP0002138_abnormal_hepatobiliary_system | 2.71660032 |
11 | MP0005083_abnormal_biliary_tract | 2.61561731 |
12 | MP0001666_abnormal_nutrient_absorption | 2.59171936 |
13 | MP0003191_abnormal_cellular_cholesterol | 2.53261826 |
14 | MP0005332_abnormal_amino_acid | 2.47089030 |
15 | MP0010155_abnormal_intestine_physiology | 2.29527127 |
16 | MP0000609_abnormal_liver_physiology | 2.20371104 |
17 | MP0004019_abnormal_vitamin_homeostasis | 2.09624410 |
18 | MP0003195_calcinosis | 2.08979813 |
19 | MP0002118_abnormal_lipid_homeostasis | 1.98878585 |
20 | MP0005319_abnormal_enzyme/_coenzyme | 1.87213068 |
21 | MP0010234_abnormal_vibrissa_follicle | 1.74648199 |
22 | MP0003656_abnormal_erythrocyte_physiolo | 1.69428147 |
23 | MP0002254_reproductive_system_inflammat | 1.69052397 |
24 | MP0001764_abnormal_homeostasis | 1.64934081 |
25 | MP0003868_abnormal_feces_composition | 1.63354229 |
26 | MP0003866_abnormal_defecation | 1.60780183 |
27 | MP0004264_abnormal_extraembryonic_tissu | 1.59111942 |
28 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.53273607 |
29 | MP0005000_abnormal_immune_tolerance | 1.40441245 |
30 | MP0009643_abnormal_urine_homeostasis | 1.40136889 |
31 | MP0005058_abnormal_lysosome_morphology | 1.38465006 |
32 | MP0000465_gastrointestinal_hemorrhage | 1.38097056 |
33 | MP0002148_abnormal_hypersensitivity_rea | 1.36236362 |
34 | MP0009764_decreased_sensitivity_to | 1.32374068 |
35 | MP0001533_abnormal_skeleton_physiology | 1.25868906 |
36 | MP0003011_delayed_dark_adaptation | 1.24937971 |
37 | MP0000598_abnormal_liver_morphology | 1.21156824 |
38 | MP0009697_abnormal_copulation | 1.19943285 |
39 | MP0001835_abnormal_antigen_presentation | 1.19704662 |
40 | MP0008469_abnormal_protein_level | 1.19356421 |
41 | MP0003763_abnormal_thymus_physiology | 1.16238590 |
42 | MP0005409_darkened_coat_color | 1.15338685 |
43 | MP0003186_abnormal_redox_activity | 1.12572184 |
44 | MP0008004_abnormal_stomach_pH | 1.11792560 |
45 | MP0001819_abnormal_immune_cell | 1.10581911 |
46 | MP0002420_abnormal_adaptive_immunity | 1.10578208 |
47 | MP0000604_amyloidosis | 1.09927329 |
48 | MP0008260_abnormal_autophagy | 1.07263181 |
49 | MP0009763_increased_sensitivity_to | 1.06143834 |
50 | MP0001873_stomach_inflammation | 1.05766443 |
51 | MP0010368_abnormal_lymphatic_system | 1.05515803 |
52 | MP0009333_abnormal_splenocyte_physiolog | 1.05208627 |
53 | MP0005647_abnormal_sex_gland | 1.05114575 |
54 | MP0005451_abnormal_body_composition | 1.03708958 |
55 | MP0002396_abnormal_hematopoietic_system | 1.02874605 |
56 | MP0005464_abnormal_platelet_physiology | 1.02729084 |
57 | MP0003705_abnormal_hypodermis_morpholog | 1.02081369 |
58 | MP0000490_abnormal_crypts_of | 0.99954573 |
59 | MP0005636_abnormal_mineral_homeostasis | 0.98088258 |
60 | MP0003436_decreased_susceptibility_to | 0.97805776 |
61 | MP0001765_abnormal_ion_homeostasis | 0.97762320 |
62 | MP0001853_heart_inflammation | 0.97376890 |
63 | MP0005670_abnormal_white_adipose | 0.95076786 |
64 | MP0002998_abnormal_bone_remodeling | 0.94175352 |
65 | MP0006082_CNS_inflammation | 0.93828064 |
66 | MP0003690_abnormal_glial_cell | 0.90696936 |
67 | MP0005408_hypopigmentation | 0.89737841 |
68 | MP0009642_abnormal_blood_homeostasis | 0.89503778 |
69 | MP0001664_abnormal_digestion | 0.88313006 |
70 | MP0001663_abnormal_digestive_system | 0.86008713 |
71 | MP0009765_abnormal_xenobiotic_induced | 0.85587929 |
72 | MP0003828_pulmonary_edema | 0.85072679 |
73 | MP0001881_abnormal_mammary_gland | 0.84514772 |
74 | MP0004130_abnormal_muscle_cell | 0.84277228 |
75 | MP0000716_abnormal_immune_system | 0.80869799 |
76 | MP0005084_abnormal_gallbladder_morpholo | 0.79417828 |
77 | MP0002078_abnormal_glucose_homeostasis | 0.79377698 |
78 | MP0005220_abnormal_exocrine_pancreas | 0.79191782 |
79 | MP0005334_abnormal_fat_pad | 0.77930439 |
80 | MP0003300_gastrointestinal_ulcer | 0.76632794 |
81 | MP0000858_altered_metastatic_potential | 0.75993518 |
82 | MP0005376_homeostasis/metabolism_phenot | 0.75700953 |
83 | MP0003724_increased_susceptibility_to | 0.74693239 |
84 | MP0002928_abnormal_bile_duct | 0.74663354 |
85 | MP0000477_abnormal_intestine_morphology | 0.74477758 |
86 | MP0006036_abnormal_mitochondrial_physio | 0.73717683 |
87 | MP0002419_abnormal_innate_immunity | 0.73299868 |
88 | MP0002876_abnormal_thyroid_physiology | 0.72876435 |
89 | MP0005535_abnormal_body_temperature | 0.72106218 |
90 | MP0001851_eye_inflammation | 0.71970628 |
91 | MP0002405_respiratory_system_inflammati | 0.71106171 |
92 | MP0004883_abnormal_blood_vessel | 0.70107674 |
93 | MP0002971_abnormal_brown_adipose | 0.70102970 |
94 | MP0003879_abnormal_hair_cell | 0.68593925 |
95 | MP0001756_abnormal_urination | 0.66526845 |
96 | MP0002136_abnormal_kidney_physiology | 0.66469095 |
97 | MP0005165_increased_susceptibility_to | 0.66288371 |
98 | MP0001845_abnormal_inflammatory_respons | 0.65541631 |
99 | MP0001790_abnormal_immune_system | 0.65240507 |
100 | MP0005387_immune_system_phenotype | 0.65240507 |
101 | MP0003172_abnormal_lysosome_physiology | 0.64476451 |
102 | MP0000685_abnormal_immune_system | 0.63424365 |
103 | MP0003075_altered_response_to | 0.62629814 |
104 | MP0004147_increased_porphyrin_level | 0.62263834 |
105 | MP0005167_abnormal_blood-brain_barrier | 0.61566677 |
106 | MP0002166_altered_tumor_susceptibility | 0.60916974 |
107 | MP0005266_abnormal_metabolism | 0.59478270 |
108 | MP0005025_abnormal_response_to | 0.58951236 |
109 | MP0001800_abnormal_humoral_immune | 0.58911961 |
110 | MP0003638_abnormal_response/metabolism_ | 0.57701088 |
111 | MP0004782_abnormal_surfactant_physiolog | 0.54785986 |
112 | MP0005448_abnormal_energy_balance | 0.54220119 |
113 | MP0004947_skin_inflammation | 0.53608170 |
114 | MP0008872_abnormal_physiological_respon | 0.53561912 |
115 | MP0000249_abnormal_blood_vessel | 0.53407595 |
116 | MP0008873_increased_physiological_sensi | 0.52001468 |
117 | MP0005671_abnormal_response_to | 0.50662230 |
118 | MP0005166_decreased_susceptibility_to | 0.50315504 |
119 | MP0002837_dystrophic_cardiac_calcinosis | 0.48738588 |
120 | MP0002132_abnormal_respiratory_system | 0.47703124 |
121 | MP0008874_decreased_physiological_sensi | 0.47273570 |
122 | MP0003303_peritoneal_inflammation | 0.47256238 |
123 | MP0009115_abnormal_fat_cell | 0.46290306 |
124 | MP0009384_cardiac_valve_regurgitation | 0.45671578 |
125 | MP0009785_altered_susceptibility_to | 0.45312671 |
126 | MP0002723_abnormal_immune_serum | 0.44491878 |
127 | MP0005666_abnormal_adipose_tissue | 0.43896663 |
128 | MP0002452_abnormal_antigen_presenting | 0.42747932 |
129 | MP0000639_abnormal_adrenal_gland | 0.42747836 |
130 | MP0004510_myositis | 0.41662700 |
131 | MP0001661_extended_life_span | 0.40373115 |
132 | MP0003183_abnormal_peptide_metabolism | 0.40194843 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.49846475 |
2 | Deep venous thrombosis (HP:0002625) | 6.32368214 |
3 | Intrahepatic cholestasis (HP:0001406) | 6.29002417 |
4 | Xanthomatosis (HP:0000991) | 5.89474087 |
5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.76927606 |
6 | Prolonged partial thromboplastin time (HP:0003645) | 5.67172091 |
7 | Complement deficiency (HP:0004431) | 5.51030318 |
8 | Hypobetalipoproteinemia (HP:0003563) | 5.39130086 |
9 | Hyperlipoproteinemia (HP:0010980) | 4.92014688 |
10 | Joint hemorrhage (HP:0005261) | 4.55513187 |
11 | Hypolipoproteinemia (HP:0010981) | 4.17262690 |
12 | Abnormality of the common coagulation pathway (HP:0010990) | 4.16686698 |
13 | Epidermoid cyst (HP:0200040) | 4.14664059 |
14 | Abnormality of complement system (HP:0005339) | 4.08434357 |
15 | Eczematoid dermatitis (HP:0000976) | 3.97843706 |
16 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.95649037 |
17 | Hyperammonemia (HP:0001987) | 3.95422645 |
18 | Ketosis (HP:0001946) | 3.94931189 |
19 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.92232313 |
20 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.82399801 |
21 | Chronic diarrhea (HP:0002028) | 3.79209128 |
22 | Hypoglycemic coma (HP:0001325) | 3.77164364 |
23 | Hypoalphalipoproteinemia (HP:0003233) | 3.76002129 |
24 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.73238357 |
25 | Abnormality of methionine metabolism (HP:0010901) | 3.72881729 |
26 | Fat malabsorption (HP:0002630) | 3.70936540 |
27 | Systemic lupus erythematosus (HP:0002725) | 3.69743058 |
28 | Hyperglycinemia (HP:0002154) | 3.64484931 |
29 | Hyperglycinuria (HP:0003108) | 3.61297617 |
30 | Abnormality of the intrinsic pathway (HP:0010989) | 3.57847683 |
31 | Hypercholesterolemia (HP:0003124) | 3.53806798 |
32 | Conjugated hyperbilirubinemia (HP:0002908) | 3.45617112 |
33 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.44534221 |
34 | Abnormality of glycine metabolism (HP:0010895) | 3.44534221 |
35 | Myocardial infarction (HP:0001658) | 3.40805194 |
36 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.29988921 |
37 | Hyperbilirubinemia (HP:0002904) | 3.29206047 |
38 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.29019334 |
39 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.13203877 |
40 | Delayed CNS myelination (HP:0002188) | 3.06884731 |
41 | Ketoacidosis (HP:0001993) | 3.01525980 |
42 | Hepatocellular carcinoma (HP:0001402) | 2.97914666 |
43 | Glomerulonephritis (HP:0000099) | 2.94023320 |
44 | Abnormality of nucleobase metabolism (HP:0010932) | 2.87796905 |
45 | Abnormality of macrophages (HP:0004311) | 2.78853894 |
46 | Recurrent abscess formation (HP:0002722) | 2.76978886 |
47 | Acanthocytosis (HP:0001927) | 2.75321370 |
48 | Abnormality of purine metabolism (HP:0004352) | 2.75093419 |
49 | Steatorrhea (HP:0002570) | 2.75014462 |
50 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.74232311 |
51 | Orchitis (HP:0100796) | 2.73237507 |
52 | Myositis (HP:0100614) | 2.70533102 |
53 | Metabolic acidosis (HP:0001942) | 2.62274055 |
54 | Widely patent fontanelles and sutures (HP:0004492) | 2.60559581 |
55 | Hypoglycemic seizures (HP:0002173) | 2.59722066 |
56 | Poikilocytosis (HP:0004447) | 2.58413765 |
57 | Gout (HP:0001997) | 2.53816962 |
58 | Gingival bleeding (HP:0000225) | 2.52492096 |
59 | Spontaneous hematomas (HP:0007420) | 2.50529384 |
60 | Skin nodule (HP:0200036) | 2.50403015 |
61 | Generalized aminoaciduria (HP:0002909) | 2.49578218 |
62 | Vascular calcification (HP:0004934) | 2.48141881 |
63 | Gingivitis (HP:0000230) | 2.46780204 |
64 | Hypochromic microcytic anemia (HP:0004840) | 2.46737115 |
65 | Recurrent bacterial skin infections (HP:0005406) | 2.45376064 |
66 | Abnormality of serum amino acid levels (HP:0003112) | 2.45237987 |
67 | Mitral stenosis (HP:0001718) | 2.44383204 |
68 | Late onset (HP:0003584) | 2.42697286 |
69 | Spontaneous abortion (HP:0005268) | 2.42432521 |
70 | Hypophosphatemia (HP:0002148) | 2.41587756 |
71 | Thin bony cortex (HP:0002753) | 2.39543660 |
72 | Renal cortical cysts (HP:0000803) | 2.39482405 |
73 | Esophageal varix (HP:0002040) | 2.37239443 |
74 | Abnormal gallbladder morphology (HP:0012437) | 2.36167531 |
75 | Nausea (HP:0002018) | 2.35332931 |
76 | Decreased circulating renin level (HP:0003351) | 2.33824478 |
77 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.30050668 |
78 | Dicarboxylic aciduria (HP:0003215) | 2.30050668 |
79 | Sensorimotor neuropathy (HP:0007141) | 2.29893929 |
80 | Brushfield spots (HP:0001088) | 2.29317769 |
81 | Retrobulbar optic neuritis (HP:0100654) | 2.28299060 |
82 | Optic neuritis (HP:0100653) | 2.28299060 |
83 | Cholelithiasis (HP:0001081) | 2.26791207 |
84 | Abnormality of vitamin metabolism (HP:0100508) | 2.26397547 |
85 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.25788360 |
86 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.25215073 |
87 | Vacuolated lymphocytes (HP:0001922) | 2.23698583 |
88 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.23215246 |
89 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.23215246 |
90 | Abnormality of glycolipid metabolism (HP:0010969) | 2.23215246 |
91 | Abnormality of iron homeostasis (HP:0011031) | 2.22634312 |
92 | Amyloidosis (HP:0011034) | 2.21567201 |
93 | Pulmonary embolism (HP:0002204) | 2.20558058 |
94 | Irritability (HP:0000737) | 2.17093578 |
95 | Hyperactive renin-angiotensin system (HP:0000841) | 2.15913262 |
96 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.15231677 |
97 | Mucopolysacchariduria (HP:0008155) | 2.15231677 |
98 | Vasculitis (HP:0002633) | 2.14929599 |
99 | Polycythemia (HP:0001901) | 2.13854436 |
100 | Cardiovascular calcification (HP:0011915) | 2.13430901 |
101 | Gastrointestinal infarctions (HP:0005244) | 2.12731908 |
102 | Lethargy (HP:0001254) | 2.11884030 |
103 | Pigmentary retinal degeneration (HP:0001146) | 2.10983981 |
104 | Thrombophlebitis (HP:0004418) | 2.10868911 |
105 | Meningitis (HP:0001287) | 2.10208012 |
106 | Dysostosis multiplex (HP:0000943) | 2.09895070 |
107 | Abnormality of vitamin B metabolism (HP:0004340) | 2.09307048 |
108 | Spastic diplegia (HP:0001264) | 2.08162077 |
109 | Abdominal distention (HP:0003270) | 2.07864377 |
110 | Pancreatitis (HP:0001733) | 2.07227975 |
111 | Menorrhagia (HP:0000132) | 2.06352821 |
112 | Joint swelling (HP:0001386) | 2.06318633 |
113 | Glycosuria (HP:0003076) | 2.06227972 |
114 | Abnormality of urine glucose concentration (HP:0011016) | 2.06227972 |
115 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.05593862 |
116 | Enlarged kidneys (HP:0000105) | 2.05013751 |
117 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.03810944 |
118 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.03810944 |
119 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.03810944 |
120 | Ileus (HP:0002595) | 2.03014233 |
121 | Abnormality of proline metabolism (HP:0010907) | 2.02801267 |
122 | Hydroxyprolinuria (HP:0003080) | 2.02801267 |
123 | Increased cerebral lipofuscin (HP:0011813) | 2.02784196 |
124 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.02143163 |
125 | Nephritis (HP:0000123) | 1.99463659 |
126 | Reticulocytosis (HP:0001923) | 1.97844363 |
127 | Increased CSF protein (HP:0002922) | 1.96135315 |
128 | Encephalitis (HP:0002383) | 1.94221735 |
129 | Neonatal onset (HP:0003623) | 1.93747078 |
130 | Malnutrition (HP:0004395) | 1.91140976 |
131 | Pulmonary infiltrates (HP:0002113) | 1.91095226 |
132 | Hemorrhage of the eye (HP:0011885) | 1.90995057 |
133 | Purpura (HP:0000979) | 1.90928007 |
134 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.89198520 |
135 | Inflammation of the large intestine (HP:0002037) | 1.88832887 |
136 | Vomiting (HP:0002013) | 1.88632623 |
137 | Mediastinal lymphadenopathy (HP:0100721) | 1.86060943 |
138 | Cerebral edema (HP:0002181) | 1.85464384 |
139 | Symptomatic seizures (HP:0011145) | 1.84265780 |
140 | Abnormality of the gallbladder (HP:0005264) | 1.84203771 |
141 | Opisthotonus (HP:0002179) | 1.84200410 |
142 | Loss of speech (HP:0002371) | 1.84092880 |
143 | Abnormal gallbladder physiology (HP:0012438) | 1.84077218 |
144 | Cholecystitis (HP:0001082) | 1.84077218 |
145 | Rickets (HP:0002748) | 1.83795190 |
146 | Chronic obstructive pulmonary disease (HP:0006510) | 1.83633393 |
147 | Obstructive lung disease (HP:0006536) | 1.83633393 |
148 | Epistaxis (HP:0000421) | 1.83628476 |
149 | Hemoptysis (HP:0002105) | 1.82570097 |
150 | Elevated alkaline phosphatase (HP:0003155) | 1.81837333 |
151 | Bone pain (HP:0002653) | 1.81465223 |
152 | Status epilepticus (HP:0002133) | 1.81413920 |
153 | Cerebral palsy (HP:0100021) | 1.81302007 |
154 | Elevated hepatic transaminases (HP:0002910) | 1.80558412 |
155 | Pustule (HP:0200039) | 1.80080971 |
156 | Alkalosis (HP:0001948) | 1.79568616 |
157 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.79105042 |
158 | Gastrointestinal inflammation (HP:0004386) | 1.79011648 |
159 | Metabolic alkalosis (HP:0200114) | 1.75718024 |
160 | Recurrent fungal infections (HP:0002841) | 1.75295813 |
161 | Asymmetric septal hypertrophy (HP:0001670) | 1.74901985 |
162 | Nephrolithiasis (HP:0000787) | 1.74754042 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 4.50420602 |
2 | ACVR1B | 4.18394534 |
3 | ERN1 | 3.73245202 |
4 | FGFR4 | 3.61286496 |
5 | TAOK3 | 3.36827275 |
6 | TYK2 | 3.34328656 |
7 | SIK1 | 3.32230642 |
8 | INSRR | 3.00447950 |
9 | RIPK4 | 2.88997307 |
10 | PRPF4B | 2.68225547 |
11 | MAP3K14 | 2.38621691 |
12 | TGFBR2 | 2.17754622 |
13 | TBK1 | 2.06751664 |
14 | FLT3 | 2.05187874 |
15 | JAK1 | 1.98819835 |
16 | MAP2K3 | 1.98381843 |
17 | IRAK3 | 1.95461934 |
18 | PRKG2 | 1.79985298 |
19 | MAP4K1 | 1.79799116 |
20 | MAPK15 | 1.72085723 |
21 | TRIB3 | 1.67234606 |
22 | CSF1R | 1.64382432 |
23 | JAK2 | 1.60589938 |
24 | MAPK11 | 1.59803905 |
25 | BLK | 1.59679599 |
26 | GRK6 | 1.49309804 |
27 | PTK6 | 1.49254647 |
28 | MAP3K2 | 1.46724611 |
29 | NEK9 | 1.45929380 |
30 | FES | 1.43074761 |
31 | PKN2 | 1.41587576 |
32 | PRKAA2 | 1.40139824 |
33 | MAP3K1 | 1.37673562 |
34 | EPHB1 | 1.34908062 |
35 | IKBKE | 1.34201587 |
36 | KDR | 1.29770110 |
37 | IKBKB | 1.29365410 |
38 | PIK3CG | 1.25841448 |
39 | ERBB4 | 1.25722610 |
40 | ZAP70 | 1.19749963 |
41 | MAP3K3 | 1.17900870 |
42 | CSK | 1.15617957 |
43 | KIT | 1.15002553 |
44 | MAP3K12 | 1.12752686 |
45 | JAK3 | 1.11954911 |
46 | TESK2 | 1.11700115 |
47 | KSR2 | 1.11022939 |
48 | MAP2K4 | 1.10443020 |
49 | FRK | 1.09417709 |
50 | PINK1 | 1.05079740 |
51 | MST1R | 1.00530685 |
52 | MATK | 0.98691311 |
53 | CHUK | 0.97562283 |
54 | FGFR3 | 0.96198149 |
55 | MAPK12 | 0.94038858 |
56 | HCK | 0.89147526 |
57 | MAP3K7 | 0.88994233 |
58 | EPHA3 | 0.87601860 |
59 | CDC42BPA | 0.85942501 |
60 | MAP3K10 | 0.85676713 |
61 | STK24 | 0.85610049 |
62 | FER | 0.82382214 |
63 | MYLK | 0.82178860 |
64 | CAMK1D | 0.80858368 |
65 | LATS1 | 0.80734698 |
66 | CDK6 | 0.80556216 |
67 | TIE1 | 0.80339117 |
68 | STK10 | 0.80165804 |
69 | IRAK4 | 0.78755628 |
70 | GRK1 | 0.76364978 |
71 | MAPK4 | 0.73683642 |
72 | MAP3K13 | 0.73444407 |
73 | TAOK1 | 0.73029561 |
74 | TESK1 | 0.72785616 |
75 | ITK | 0.72053179 |
76 | SGK3 | 0.70305434 |
77 | SYK | 0.70048165 |
78 | MAP2K6 | 0.66477351 |
79 | FGR | 0.66173565 |
80 | DYRK1B | 0.65281087 |
81 | DAPK2 | 0.64603297 |
82 | PKN1 | 0.64570649 |
83 | PRKAA1 | 0.61998097 |
84 | PTK2 | 0.61585234 |
85 | AKT3 | 0.61406961 |
86 | STK38 | 0.59004583 |
87 | SIK3 | 0.58594461 |
88 | TAOK2 | 0.58299093 |
89 | PRKCZ | 0.57561448 |
90 | YES1 | 0.57157089 |
91 | FYN | 0.56974802 |
92 | MAPK7 | 0.56775836 |
93 | TEC | 0.55937728 |
94 | MAP2K2 | 0.55531233 |
95 | SCYL2 | 0.55321937 |
96 | PRKACG | 0.55197420 |
97 | CAMKK2 | 0.54681987 |
98 | GSK3A | 0.54647957 |
99 | IGF1R | 0.54522396 |
100 | LYN | 0.54464408 |
101 | DDR2 | 0.54143127 |
102 | BMPR1B | 0.53854164 |
103 | TNK2 | 0.53775378 |
104 | BTK | 0.53685077 |
105 | ABL2 | 0.52839893 |
106 | PRKCQ | 0.51797299 |
107 | NLK | 0.50016485 |
108 | PDPK1 | 0.49472169 |
109 | EPHA2 | 0.48330032 |
110 | PDK1 | 0.47127650 |
111 | GRK7 | 0.45933070 |
112 | CAMK1G | 0.45242618 |
113 | PRKCD | 0.44904244 |
114 | PIM1 | 0.43896950 |
115 | ARAF | 0.43673121 |
116 | SGK2 | 0.42609819 |
117 | TRPM7 | 0.42442568 |
118 | MAP3K11 | 0.42099193 |
119 | PDK2 | 0.40132004 |
120 | RET | 0.40099584 |
121 | FGFR2 | 0.40059287 |
122 | PIK3CA | 0.39653274 |
123 | LCK | 0.39644057 |
124 | LRRK2 | 0.38413381 |
125 | TXK | 0.37729010 |
126 | ERBB2 | 0.37462969 |
127 | MET | 0.35637084 |
128 | MAP3K5 | 0.34797717 |
129 | EGFR | 0.34675849 |
130 | IRAK1 | 0.34538475 |
131 | STK4 | 0.33659426 |
132 | RIPK1 | 0.32439755 |
133 | BMPR2 | 0.30110651 |
134 | MAP3K6 | 0.29735508 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.38726661 |
2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.31751396 |
3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.30592519 |
4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.23324977 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.83407675 |
6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.80605475 |
7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.72519449 |
8 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.64823001 |
9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.49164521 |
10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.39302310 |
11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.38655158 |
12 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.38436384 |
13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.31817638 |
14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.21654998 |
15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.16682949 |
16 | Peroxisome_Homo sapiens_hsa04146 | 2.10466808 |
17 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.04653148 |
18 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.97358455 |
19 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.97012922 |
20 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.93869605 |
21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.88784760 |
22 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.84163101 |
23 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.83564269 |
24 | Histidine metabolism_Homo sapiens_hsa00340 | 1.78674097 |
25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.75366908 |
26 | Retinol metabolism_Homo sapiens_hsa00830 | 1.74754853 |
27 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.73459578 |
28 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.72907890 |
29 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.61666562 |
30 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.59292226 |
31 | Bile secretion_Homo sapiens_hsa04976 | 1.53247202 |
32 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.51951709 |
33 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.47882037 |
34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.44907647 |
35 | ABC transporters_Homo sapiens_hsa02010 | 1.43464533 |
36 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.42096477 |
37 | Mineral absorption_Homo sapiens_hsa04978 | 1.39722175 |
38 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.38058073 |
39 | Allograft rejection_Homo sapiens_hsa05330 | 1.35714942 |
40 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.28938415 |
41 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.26805243 |
42 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.26651096 |
43 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.25495582 |
44 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.24968402 |
45 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.22868292 |
46 | Asthma_Homo sapiens_hsa05310 | 1.21016737 |
47 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.18588746 |
48 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.18110222 |
49 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.17157948 |
50 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.12827884 |
51 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.12443102 |
52 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.10456508 |
53 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.09456125 |
54 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.04382004 |
55 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.99084432 |
56 | Carbon metabolism_Homo sapiens_hsa01200 | 0.95851403 |
57 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.94972211 |
58 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.93966078 |
59 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.93789840 |
60 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.93117199 |
61 | Sulfur relay system_Homo sapiens_hsa04122 | 0.88567966 |
62 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.88343869 |
63 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.87895739 |
64 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.84246400 |
65 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.80044015 |
66 | Lysine degradation_Homo sapiens_hsa00310 | 0.77524524 |
67 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.76273018 |
68 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.73477662 |
69 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.71079849 |
70 | Tuberculosis_Homo sapiens_hsa05152 | 0.67108550 |
71 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.66337685 |
72 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.59882464 |
73 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.53284352 |
74 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.52905038 |
75 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.52876678 |
76 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.49293668 |
77 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.49273177 |
78 | Viral myocarditis_Homo sapiens_hsa05416 | 0.49272378 |
79 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.48723144 |
80 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.48464493 |
81 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.47750537 |
82 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.45060075 |
83 | Other glycan degradation_Homo sapiens_hsa00511 | 0.44606985 |
84 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.44496076 |
85 | Insulin resistance_Homo sapiens_hsa04931 | 0.43445896 |
86 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.42956780 |
87 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.41639898 |
88 | Metabolic pathways_Homo sapiens_hsa01100 | 0.40386656 |
89 | Prion diseases_Homo sapiens_hsa05020 | 0.39754818 |
90 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.38764922 |
91 | Influenza A_Homo sapiens_hsa05164 | 0.38361611 |
92 | Galactose metabolism_Homo sapiens_hsa00052 | 0.38007680 |
93 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.37257851 |
94 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.36842045 |
95 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.36553231 |
96 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.36540546 |
97 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.35393858 |
98 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.34829182 |
99 | Phagosome_Homo sapiens_hsa04145 | 0.33991398 |
100 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.33588100 |
101 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.31246542 |
102 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.31171976 |
103 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.30585755 |
104 | Amoebiasis_Homo sapiens_hsa05146 | 0.29523236 |
105 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.29464763 |
106 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.28565511 |
107 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.28200084 |
108 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.27023385 |
109 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.26788330 |
110 | Lysosome_Homo sapiens_hsa04142 | 0.25917131 |
111 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.15686301 |
112 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.08044729 |
113 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.05979480 |
114 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.03951128 |
115 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.02665563 |
116 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.02422788 |
117 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1282701 |
118 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.1281255 |
119 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1152440 |
120 | Toxoplasmosis_Homo sapiens_hsa05145 | -0.1081115 |
121 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0980641 |
122 | Osteoclast differentiation_Homo sapiens_hsa04380 | -0.0979338 |
123 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0868144 |
124 | Leishmaniasis_Homo sapiens_hsa05140 | -0.0835819 |
125 | Legionellosis_Homo sapiens_hsa05134 | -0.0700985 |
126 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0693379 |
127 | Hepatitis C_Homo sapiens_hsa05160 | -0.0446558 |
128 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | -0.0441457 |
129 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | -0.0321724 |
130 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | -0.0276458 |
131 | Pertussis_Homo sapiens_hsa05133 | -0.0116116 |